Other
Surgical Site Infection
5
Pipeline Programs↗
10
Active Trials↗
1
Companies Involved↗
Surgical Site Infection is an early-stage landscape with 5 programs across 1 company. The most active players are Merck & Co.. 1 program is in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical4
Phase 1
No programs
Phase 2
No programs
Phase 31
Approved
No programs
Analysis
Trial Status
41
clinical trials
Completed16 · 39%
Unknown status10 · 24%
Recruiting9 · 22%
Terminated3 · 7%
Withdrawn2 · 5%
Active, not recruiting1 · 2%
Clinical Trials
Trial Activity
41 trials
Prevention of Surgical Site Infection in Open Paediatric Groin Surgeries Using Intravenous Prophylactic Antibiotics and Antimicrobial-coated Sutures
Recruiting·—·N/A·NCT07346742·174 enrolled
Does a Preoperative Prophylactic Antibiotic Reduce Surgical Site Infection Following Wire-localized Lumpectomy
Completed·—·N/A·NCT04818931·326 enrolled
Antibiotic Prophylaxis in Clean Surgery. Impact on Surgical Site Infection
Completed·—·N/A·NCT03595852·138 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)